Skip to content

Diet and exercise interventions improve health markers in individuals with an increased risk of disease

Carbohydrate-restricted diet and HIIT exercise improves cardio-metabolic, inflammatory profiles, and cognition in metabolic syndrome: a randomized crossover trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN13184253
Enrollment
12
Registered
2018-04-18
Start date
2016-04-20
Completion date
Unknown
Last updated
2018-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic syndrome, according to the National Cholesterol Education Program-Adult Treatment Panel III Nutritional, Metabolic, Endocrine Metabolic syndrome

Interventions

The two phases of the crossover design included a carbohydrate-restricted Paleolithic-based diet with sedentary behavior (CRPD-Sed) and a carbohydrate-restricted Paleolithic-based diet with high inten

Sponsors

Grand Valley State University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18-60 years 2. Metabolic syndrome (MetS), according to the National Cholesterol Education Program-Adult Treatment Panel III. 3. Stable weight for at least 3 months 4. Relatively sedentary (defined as engaged in exercise <30 min/day or VO2 peak <45 ml/kg/min)

Exclusion criteria

Exclusion criteria: 1. Special diets 2. Medications for chronic disease 3. Cardiovascular, metabolic, pulmonary, or osteoarticular disease

Design outcomes

Primary

MeasureTime frame
Cardiovascular and metabolic health were assessed following 4 weeks of diet or diet and exercise intervention. Blood was collected at 0, 4, 8, and 12 weeks. Assessments included lipoprotein markers (Cholestech LDX® system), adiposity (hydrostatic weighing), metabolic markers (enzyme-linked immunosorbent assay) and VO2max (peak exercise test).

Secondary

MeasureTime frame
Cognition functioning was assessed using Brain-Derived Neurotrophic Factor protein content (enzyme-linked immunosorbent assay), performance on the Stroop Test, as well as a self-reported measure of cognitive symptoms and function (Medical Outcomes Study Cognitive Functional Scale).

Countries

United States of America

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026